Price Alert

Biogen Inc. (BIIB)

NASDAQ: BIIB · Real-Time Price · USD

138.66

3.72 (2.76%)

At close: Aug 15, 2025, 3:59 PM

139.59

0.67%

After-hours: Aug 15, 2025, 07:58 PM EDT

Biogen Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	2.65B	2.43B	2.45B	2.47B	2.46B	2.29B	2.39B	2.53B	2.46B	2.46B	2.54B	2.51B	2.59B	2.53B	2.73B	2.78B	2.77B	2.69B
Cost of Revenue	605M	629.3M	583.5M	638.7M	546M	542.2M	618.3M	659.6M	592.7M	662.8M	570.9M	469.5M	484M	753.9M	660.1M	511.8M	459.7M	478.1M
Gross Profit	2.04B	1.8B	1.87B	1.83B	1.92B	1.75B	1.77B	1.87B	1.86B	1.8B	1.97B	2.04B	2.11B	1.78B	2.07B	2.27B	2.32B	2.22B
Operating Income	851.8M	625.2M	450.6M	496.4M	701.9M	577.5M	425.2M	n/a	621.3M	517.3M	528.5M	824.7M	907M	610.7M	587.1M	794M	485.7M	973.9M
Interest Income	32.3M	23.9M	18.5M	11.6M	20.1M	17.4M	23.8M	95.9M	75.9M	80.9M	49.9M	23.9M	12.6M	2.9M	2.8M	2.6M	2.7M	2.9M
Pretax Income	744M	311.2M	291.5M	451M	698.7M	464.8M	291.6M	-141.2M	708.1M	438.3M	603.8M	1.37B	1.27B	347.4M	405M	291.1M	582.1M	467M
Net Income	634.8M	240.5M	266.7M	388.5M	583.6M	393.4M	249.7M	-68.1M	591.6M	387.9M	550.4M	1.13B	1.06B	303.8M	368.2M	329.2M	448.5M	410.2M
Selling & General & Admin	583.8M	572.5M	680M	588.4M	553.8M	581.5M	608.5M	788.2M	548M	605M	632.8M	563.3M	572.6M	634.9M	787.9M	654.1M	637.3M	595M
Research & Development	399M	434.1M	532.3M	542.7M	513.9M	445.4M	647.5M	736.3M	584.2M	570.6M	601.6M	549.2M	528.6M	551.7M	699.5M	702.4M	585.1M	514.2M
Other Expenses	205.9M	169.9M	208.3M	199.6M	149.3M	143.9M	130.9M	-300M	109.8M	107.3M	210.2M	101.8M	96.9M	-50.4M	-800K	116.6M	607.2M	132.8M
Operating Expenses	1.19B	1.18B	1.42B	1.33B	1.22B	1.17B	1.26B	1.55B	1.24B	1.28B	1.44B	1.21B	1.2B	1.14B	1.49B	1.47B	1.84B	1.24B
Interest Expense	72.6M	60M	60M	59.8M	61.3M	69.2M	71.5M	63.8M	49.1M	62.5M	54.8M	59.9M	65.8M	66.1M	66.3M	66.3M	56.4M	64.7M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	71.4M	n/a	n/a	n/a	54.1M	n/a	n/a	n/a	98.7M	n/a	n/a	n/a
Cost & Expenses	1.79B	1.81B	2B	1.97B	1.76B	1.71B	1.93B	2.3B	1.83B	1.95B	2.02B	1.68B	1.65B	1.94B	2.15B	2B	2.27B	1.72B
Income Tax Expense	109.2M	70.7M	24.8M	62.5M	115.1M	71.4M	42.7M	-72.9M	114.8M	50.7M	54.3M	236.2M	216.7M	125.6M	443.2M	-25.9M	-409.1M	44.2M
Shares Outstanding (Basic)	145.9M	145.9M	145.7M	145.7M	145.6M	145.2M	144.9M	144.8M	144.7M	144.4M	144.1M	144.4M	145.9M	147.1M	146.9M	148M	149.7M	151.9M
Shares Outstanding (Diluted)	145.9M	145.9M	146.1M	145.9M	145.9M	145.9M	145.7M	144.8M	145.5M	145.2M	145.2M	144.8M	146.2M	147.6M	147.5M	148.6M	150.1M	152.3M
EPS (Basic)	4.35	1.65	1.83	2.67	4.01	2.71	1.72	-0.47	4.09	2.69	3.82	7.86	7.25	2.06	2.51	2.22	3.00	2.70
EPS (Diluted)	4.35	1.65	1.83	2.66	4.00	2.70	1.71	-0.47	4.07	2.67	3.79	7.84	7.24	2.06	2.50	2.22	2.99	2.69
EBITDA	1.01B	554.4M	535.5M	693.6M	918.9M	681.5M	601.2M	47.6M	750.7M	613.1M	764.9M	945.4M	1B	556.7M	713.1M	490.1M	711.4M	973.9M
EBIT	816.6M	371.2M	351.5M	510.8M	760M	534M	461.1M	-77.4M	757.2M	500.8M	658.6M	1.43B	1.34B	413.5M	471.3M	357.4M	638.5M	531.7M
Depreciation & Amortization	194.3M	183.2M	184M	182.8M	158.9M	147.5M	140.1M	125M	117.4M	112.3M	119.8M	120.7M	134.7M	143.2M	127.1M	132.7M	72.9M	102.6M